Martha Morrell, CHIEF MEDICAL OFFICER at NeuroPace Inc (NPCE), sold 300 shares at $15.00 ($5K) on 2025-01-29, disclosed to the SEC on 2025-01-31.
Scheduled sale ($4k) by CHIEF MEDICAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.00 | 100 | $2K | 33.3% |
| 2 | $15.00 | 200 | $3K | 66.7% |
| Total | $15.00 avg | 300 | $5K | 100% |
| Filing → |
| NPCE | SELL | 2025-01-28 | $48K | — | Filing → |
| NPCE | SELL | 2024-02-06 | $531K | — | Filing → |
| NPCE | SELL | 2024-02-01 | $379K | — | Filing → |